Virax Biolabs Group Ltd. (VRAX)
0.41
-0.04
(-9.67%)
USD |
NASDAQ |
Dec 15, 16:00
0.4091
0.00 (0.00%)
After-Hours: 20:00
Virax Biolabs Group Market Cap: 2.683M for Dec. 15, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biodexa Pharmaceuticals Plc | 2.961M |
| NuCana Plc | 15.07M |
| Autolus Therapeutics Plc | 431.15M |
| Tiziana Life Sciences Ltd. | 188.93M |
| Aptorum Group Ltd. | 8.930M |
Market Cap Related Metrics
| PS Ratio | 622.18 |
| Price | 0.41 |
| Earnings Yield | -305.4% |